Biotechnology | FDA | HIV | Therapeutics
The FDA approved new HIV treatment for patients with limited treatment options
On Jul. 2, 2020, the U.S. Food and Drug Administration (FDA) approved Rukobia (fostemsavir), a new type of…
-
-
CDC announced action to prepare against ‘G4’ swine flu viruses in China with pandemic potential
On Jul. 2, 2020, the U.S. Centers for Disease Control and Prevention (CDC) announced a publication in the…
-
FDA issued Emergency Use Authorization for Philips’ acute care patient monitoring solutions for hospitals
On Jul. 2, 2020, Royal Philips announced that the U.S. Food and Drug Administration (FDA) had issued an…
-
TGen teamed with Poba Medical to produce 10,000 COVID-19 test kits per month
On Jul. 2, 2020, in response to the continuing need for more COVID-19 diagnostic tests, the Translational Genomics…
-
From Wuhan to San Diego – How a mutation on the novel coronavirus dominated the globe
On Jul. 2, 2020, In a new study, an international team of scientists show that the G version of…
-
UConn-made COVID-19 custom mask solution to be manufactured
On Jul. 2, 2020, UConn announced a licensing deal with Connecticut Biotech, a startup company headquartered in South…
-
Biotechnology | FDA | HIV | Therapeutics
ViiV Healthcare announced FDA approval for Rukobia (fostemsavir), a first-in-class treatment for HIV in adults
On Jul. 2, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the US Food…
-
Regeneron and Sanofi announced Kevzara (sarilumab) phase 3 US trial in COVID-19 patients did not meet endpoints
On Jul. 2, 2020, Regeneron and Sanofi announced that the U.S. Phase 3 trial of Kevzara (sarilumab) 400…
-
Johnson & Johnson Announced European Commission Approval for Janssen’s Preventive Ebola Vaccine
On Jul. 1, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical subsidiary received a positive opinion from…
-
AgReliant Genetics was founded
Jul. 1, 2020, was the twentieth anniversary of AgReliant Genetics’ founding by global seed companies KWS of Einbeck,…
-
Johnson & Johnson Announces European Commission Approval for Janssen’s Preventive Ebola Vaccine
On Jul. 1, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical subsidiary received a positive opinion from…
-
Intravacc in-licensed CimCure’s iBoost technology, expanding its vaccine platform portfolio
On Jul. 1, 2020, Intravacc announced the signing of a strategic partnership agreement with Dutch based CimCure, focusing…
-
Complexity of human tooth enamel revealed at atomic level in NIH-funded study
On Jul. 1, 2020, National Institutes of Health (NIH) funded scientists announced using a combination of advanced microscopy…
-
Fujifilm partnered with Dr. Reddy’s and Global Response Aid for deployment of a COVID-19 treatment drug outside of Japan
On Jul. 1, 2020, FUJIFILM announced a partnership with Dr. Reddy’s Laboratories, a global pharmaceutical company headquartered in…
-
MediciNova announced IND for MN-166 (ibudilast) for prevention of ARD Syndrome in patients with COVID-19
On Jul. 1, 2020, MediciNova announced that the Investigational New Drug Application (IND) for MN-166 (ibudilast) for prevention…
-
Merck and Ridgeback Bio announced closing of collaboration and licensing transaction
On Jul. 1, 2020, Merck and and and Ridgeback Biotherapeutics announced that the U.S. Federal Trade Commission (FTC)…
-
T2 Biosystems announces US launch of COVID-19 diagnostic test
On Jul. 1, 2020, T2 Biosystems announced completion of validation of its COVID-19 molecular diagnostic test, the T2SARS-CoV-2…
-
OPKO Health’s BioReference Laboratories reports results of COVID-19 testing for almost one quarter of a million nursing home employees
On Jul. 1, 2020, OPKO Health announced the results of COVID-19 molecular PCR and antibody tests for nursing…
-
Pfizer and BioNTech announced early positive data from ongoing phase 1/2 study of mRNA-based vaccine candidate against SARS-CoV-2
On Jul. 1, 2020, Pfizer and BioNTech announced preliminary data from the most advanced of four investigational vaccine…
-
InBios received FDA Emergency Use Authorization for second COVID-19 antibody test
On Jul. 1, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the U.S. Food…
-
UC Berkeley launched trial of saliva test for COVID-19
On Jun. 30, 2020, scientists from the Innovative Genomics Institute (IGI) at the University of California Berkeley announced…
-
Successful first harvest provided roadmap for scaling secure, domestic source of farm-raised salmon
On Jun. 30, 2020, AquaBounty Technologies announced it had successfully commenced the commercial-scale harvest of conventional Atlantic salmon…
-
Altimmune announces dosing of first patient in phase 1b clinical trial of NasoShield single dose intranasal anthrax vaccine candidate
On Jun. 30, 2020, Altimmune announced dosing of the first patient in the Company’s Phase 1b clinical trial…
-
NIH study showed genomic variation causing common autoinflammatory disease may increase resilience to bubonic plague
On Jun. 29, 2020, National Institutes of Health (NIH) researchers announced they had discovered that Mediterranean populations may…
-
U.S. Dept of Veterans Affairs launched COVID-19 screening tool
On Jun. 29, 2020, the U.S. Dept. of Veterans Affairs (VA) announced it had launched a digital COVID-19…
-
Oxford University dashboard highlighted potential future COVID-19 virus hotspots
On Jun. 29, 2020, the University of Oxford reported that potential COVID-19 hotspots can be identified using a…
-
Bharat Biotech COVID-19 vaccine – COVAXIN received DCGI approval for phase I & II Human clinical trials
On Jun. 29, 2020, Bharat Biotech announced it had successfully developed COVAXIN, India’s 1st vaccine candidate for COVID-19,…
-
Association between statewide school closure and COVID-19 incidence and mortality in the US
On Jun. 29, 2020, a study published in JAMA showed that in the U.S., states enacted nonpharmaceutical interventions,…
-
LabCorp introduced Xcellerate COVID-19 clinical study solution
On Jun. 29, 2020, LabCorp announced that Covance, its drug development business, has deployed the Xcellerate COVID-19 solution…
-
Todos Medical entered into distribution partnership with Meridian Health Services network for COVID-19 testing solutions
On Jun. 29, 2020, Todos Medical announced that it had entered into a partnership with Meridian Health Services…
